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Abstract Silver nanoparticles (AgNPs) are capable of
inhibiting the growth of a broad spectrum of bacterial
species. The minute size of the nanoparticulates enhances
their biocidal activity and is thus widely utilized as
antibacterial agents. The most recently researched and
recognized antibacterial and wound-healing properties of
published AgNPs were investigated in this article. The
following parameters of the AgNPs affecting their prop-
erties and potency were explored: particle size, shape, and
type of ligand or stabilizing agent. Research regarding the
antibacterial activity enhancement of high-valent silver
nanoparticles compared to those of the lower valent forms
were summarized and analyzed. Nanocrystalline silver is
capable of binding to components that may enhance their
preparation and antibacterial properties. By forming com-
plexes with ligands that exhibit desired properties, silver
nanoparticles can be synthesized to exhibit those desired
properties without compromising their performance. This
review will provide a detailed discussion regarding the
parameter-dependent bactericidal properties of silver
nanoparticles and nanocomposite silver complexes as
potent multifunctional wound-healing agents.
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Introduction
The use of silver as a medicinal substance dates back to the
times of Hippocrates, the father of modern medicine who
used silver’s medical properties to treat wounds [1]. His-
torically, silver was considered one of the most important
antibacterial agents before the introduction of antibiotics
[2]. Prior to the discovery of antibiotics, the desperate need
of materials with antibacterial properties was followed by
the application of silver in sutures, postoperative inflam-
mation and infection prevention, and treatment of battle
wounds during World War I. Usage of antibiotics,
enzymes, metal ions, and quaternary ammonium com-
pounds poses disadvantages, including the development of
drug resistance and detrimental effects regarding the
environment [3]. Numerous theories of the antibacterial
mechanism of silver have been suggested in the past as the
interest in silver’s ability to fight microorganisms grew.
Silver atoms are known to attach to the sulfur in thiol of
vital enzymes involved in biological processes including
ion transport and transmembrane energy generation [4].
Silver acts as a reducing agent to catalyze the reaction
between cellular oxygen and hydrogen of thiol groups
resulting in disulfide bonds [5]. Modifications in vital cel-
lular molecules can provoke alterations in the cellular
structure causing malfunctions that may finally result in
apoptosis or necrosis. Disruption of cell respiration is a
sure-fire cause of cell death. A decrease in the expression
of maltose transporter, succinyl-coenzyme A synthetase,
30S ribosomal subunit protein, and fructose bisphosphate
aldolase was observed in the cells treated with a 900 ppb
silver ion solution [6]. The silver ions deactivate the 30S
ribosomal subunit by binding to it. The deactivation of the
ribosome complex leads to the interference in the transla-
tion of proteins [6]. Succinyl-coenzyme A synthase, a
crucial component of the TCA cycle, catalyzes the reaction
that yields succinate from succinyl-CoA and simultane-
ously phosphorylates ADP to make ATP [7]. Disruption of
glycolysis via silver is caused by the deactivation of fruc-
tose bisphosphate aldolase. Fructose bisphosphate aldolase
catalyzes the cleavage of fructose-1,6-bisphosphate into
glyceraldehyde 3-phosphate and dihydroxyacetone
phosphate [7]. A maltose transporter, MalK, present in the
cytoplasmic membrane is another vital organelle affected
by the silver [8]. The disruption of any one of these pro-
cesses can contribute to the mortality of bacterial cells.
Other mechanisms regarding silver’s mechanism of action
concerns silver’s intracellular interaction with differing cell
components. Klueh et al. proposed that Ag? ions can enter
cells and denature DNA molecules especially by disrupting
the hydrogen bonds between purine and pyrimidine base
pairs [4]. The presence of numerous possible disruptions of
cell functions may explain silver’s capability of inhibiting
bacterial growth of various species. Silver is currently used
in wound dressings [9], endotracheal tubes [10], surgical
masks [11], cotton fibers [12], drinking water purification
[13], antibacterial glass [7], food packaging [14], clothing,
burn wound-care cream, and many other everyday appli-
cations. The antibacterial properties of silver are only
exhibited in its ionic form. It has been reported that non-
ionized silver from an insoluble silver source is unable to
inhibit the growth of bacteria [15]. Among silver salts,
silver sulfadiazine (AgSD) is commonly used as a source
of silver ions and is known as a broad-spectrum antimi-
crobial substance [16]. Using its wide range of effective-
ness against bacteria, silver sulfadiazine has been widely
used in burn wound-care. Topical cream containing the
AgSD is currently commercially available. In many studies
regarding the antibacterial properties of silver and silver
nanoparticles, silver sulfadiazine is considered the gold
standard and is used to compare the potency of the bacte-
ricidal activity of novel substances [17]. By first under-
standing the mechanism of action of the antibacterial
activity of silver at a molecular level, the compound can be
improved upon by not only decreasing its size, but also by
carrying out modifications that result in synergism.
Nanoparticles are categorized as particles with at least
one dimension between 1 and 100 nm [18]. These particles
are considered as the bridge between bulk materials and
atomic structures due to their size. The synthesis of
nanocomposites requires a stabilizing agent that keeps the
substance from agglomerating as a result of attractive van
der Waals forces. The range of applications for nanopar-
ticles is immense due to its versatility in functionality.
Varying the synthesis method of nanoparticles, type of
stabilizers and reducing agents used during the synthesis
vastly affects the properties of the product. Silver
nanoparticles can be synthesized by methods such as
evaporation–condensation [19], laser ablation [20], chem-
ical reduction [21], and microemulsion [22]. Certain
physical parameters, including particle size, shape, and size
distribution, alter the properties and potencies of the
nanoparticles. Thus, the nanoscale of the particles may
cause the rise of unforeseen characteristics exhibited in the
same compound in bulk. These unique properties of
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nanoparticles are the basis of its broad application in
modern technology and science. Nanoparticle-unique
properties include large surface area-to-volume ratio, uni-
formity, suspension formation, quantum confinement [23],
and surface plasmon resonance [24]. One of the most uti-
lized properties of the nanoparticles is its large surface
area-to-volume ratio. The nano-silver’s large surface area
has the effect of increasing the expression of its properties.
For example, the antibacterial activity of silver increases in
nanoparticles, due to the increase in the contact area
between the cells and the substance allowing more silver
ions to enter the cell. The driving force for diffusion, which
significantly elevates the activity of its properties, is a
product of the high surface area-to-volume ratio. Surface
plasmon resonance is used to characterize many synthe-
sized nanoparticles via UV–Vis spectrometry as its pres-
ence confirms the formation of the nanoparticles without
aggregation [25, 26]. Additionally, silver nanoparticles can
be characterized through scanning electron microscopy
(SEM), atomic force microscopy (AFM), dynamic light
scattering (DLS), transmission electron microscopy
(TEM), Fourier transform infrared spectroscopy, X-ray
photoelectron spectroscopy (XPS), and powder X-ray
diffractometry (XRD) [27]. Like other nanoparticles, the
particles’ tendency to agglomerate is one of the major
obstacles of silver nanoparticle formation. Furthermore, in
the biological experimental aspect of the silver nanoparti-
cles, the agglomeration of the AgNPs in biological media
such as DMEM tends to increase, making it difficult to
accurately study the concentration dependent effects of the
AgNPs [28]. Thus, it is important to select a ligand that is
physically suitable in preventing the agglomeration of the
silver ions at the nano-level by acting as a stabilizing agent.
Pokhrel et al. reports that certain organic ligands with the
ability to receive waters are able to differentially modify
the surface of silver nanoparticles and alter their environ-
mental persistence [29]. Silver nanoparticles are stabilized
electrostatically, sterically, and electrosterically [30]. The
conjugation of silver nanoparticles at its surface broadens
the horizon of applications since the properties of the
conjugation material are maintained after the reaction.
Thus, as long as the conjugation is successful without any
changes in the molecular structure, the conjugated silver
nanoparticles should be able to exhibit the desired prop-
erties of the ligands.
This review of silver nanoparticles offers a unique in-
depth overview of the antibacterial silver nanoparticles,
specifically in the aspects of parameter-dependent
antibacterial potency, methods of enhancing the biocidal
efficacy, and utilization of functionalized silver nanopar-
ticles as wound treatment systems. By summarizing and
integrating the parameter dependence of AgNPs’ antibac-
terial activities provides the readers of the general
overview of the parameter specific trend of the properties
of the particles, allowing them to synthesize silver
nanoparticles with the desired specifications for further
research. The various methods of enhancing the antimi-
crobial properties of the AgNPs presents diverse methods
of modifying silver nanoparticles to further aid in inhibit-
ing bacterial growth. By collecting the highlighted works in
this field, this review may allow scientists to apply specific
alterations to their own work for better results. The mar-
ketable bi-functionality of wound-healing antibacterial
silver nanoparticles has been the driving point of the usage
of AgNPs in the field. The conjugated silver nanoparticles
are discussed in detail regarding its preparation and wound-
healing promotion properties. The wound-healing promo-
tion properties in this review were focused on the materi-
als’ multifunctionality to stimulate cell proliferation and
inhibit bacterial growth, which differentiates this paper
from other reviews about silver nanoparticles.
Parameter-dependent silver nanoparticle
antibacterial properties
The antibacterial activity of silver nanoparticles is influ-
enced by the dimensions of the nanoparticles (e.g., size and
shape). Generally, smaller particles exhibit greater
antimicrobial effect [31]. The antibacterial effect of silver
nanoparticles in the size range of 1–100 nm on Gram-
negative bacteria was studied using commercially available
nanoparticle powders [32]. The antibacterial effect of silver
nanoparticles was studied with different concentrations of
prepared nano-silver (0, 25, 50, 75, 100 lg/ml) inoculated
with 10 ml of an E. coli bacterial culture. The interactions
between bacteria and nanoparticles were analyzed by the
measurement of the optical density at 595 nm. The elec-
trochemical nature of silver nanoparticles was analyzed by
stripping voltammetry. The size of silver nanoparticles was
confirmed by TEM to be in the range of 1–10 nm. A sta-
tistical study and HRTEM study confirmed that 98 % of
the particles with diameters between 1 and 10 nm were
different in shapes. The study on the effect of different
concentrations of silver nanoparticles on the growth of
bacteria demonstrated that at concentrations above 75 lg/
ml no significant bacterial growth occurred. Additionally,
the presence of silver nanoparticles in the cell membrane
and cytosol of the bacteria was confirmed by TEM. Based
on the observation of the TEM and HAADF images, the
smaller the particles size (5 nm) the higher the antibacterial
activity of the silver nanoparticles. Panacek et al. reported
a simple one pot synthesis of colloid AgNPs with different
sizes (Tollens process) [33]. In this method, four different
saccharides, glucose, galactose, maltose and lactose, were
used as reducing agents. The size of the silver colloid
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particles ranged from 25 to 100 nm on average. The syn-
thesized particles were characterized by DLS, TEM and
UV–visible absorption spectrometry. The reduction of
diamino silver ions by maltose produced silver colloid
nanoparticles with an average size of 25 nm. Through MIC
and MBC determination, it was found that the smallest
silver colloid particles size at 25 nm showed the greatest
bacterial termination and inhibition against Gram-positive
and Gram-negative bacteria including highly multi-resis-
tant strains such as methicillin-resistant Staphylococcus
aureus (MRSA). Martinez-Castanon et al. investigated the
synthesis of silver nanoparticles with different sizes (7, 29
and 89 nm) [34]. This group used gallic acid as a reducing
as well as stabilizing agent. Through TEM analysis, the
silver nanoparticles were determined to have spherical (7
and 29 nm) and pseudospherical shapes (89 nm). In order
to produce small-sized silver nanoparticles (7 and 29 nm),
this group performed a reduction reaction at pH 11 and 10,
respectively. This group used a UV light (254 nm, 25 W)
irradiation method for 30 min and heated for 30 min at
80 C to obtain 89 nm silver nanoparticles. The antibac-
terial activities of the products were tested against Gram-
negative bacteria (E. coli) and Gram-positive bacteria (S.
aureus). The 7 nm silver nanoparticles exhibited the best
antibacterial activity against both species. Because of the
miniscule nanoparticles size (7 nm) and high surface area,
silver nanoparticles with 7 nm were able to reach the
nuclear content of bacteria efficiently; therefore being able
to kill bacteria more effectively. Espinosa-Cristo´bal et al.
studied the antibacterial effect of silver nanoparticles
against Streptococcus mutans, the microorganism associ-
ated with dental caries [35]. The three differently sized
AgNPs (8.4 16.1, and 98 nm) were prepared by using a
modified reaction condition of that reported by Martinez-
Castanon et al. The morphology of silver nanoparticle with
S. mutans treatment was observed using atomic force
microscopy (AFM). The nanoparticles with an average
diameter of 8.4 nm showed better antibacterial activity
compared with those of the larger nanoparticles (16.1 and
98 nm). Espinosa-Cristo´bal et al. suggested that smaller
nanoparticles release more Ag? ions, thus causing an
increase in their antibacterial effect. Lu et al. reported on
the size-dependent antibacterial activities of AgNPs against
oral anaerobic pathogenic bacteria [36]. In this work, three
silver nanoparticles with different sizes (*5, 15 and
55 nm) were prepared by using two methods. To obtain the
smaller nanoparticles, NaBH4 was used as a reducing agent
and the larger set of particles was synthesized by PEG
reduction. The bacterial inhibition study was evaluated by
colony counting assays, growth inhibition curve method,
and corresponding MIC measurements against five anaer-
obic oral pathogenic bacteria Actinobacillus actino-
mycetemcomitans, Fusobacterium nucleatum,
Streptococcus mutans, Streptococcus sanguis, Streptococ-
cus mitis and aerobic bacteria E. coli. The antibacterial
effects of the particles against anaerobic bacteria were
lower than those against aerobic bacteria. Thus, it can be
inferred that the aerobic bacteria were more susceptible to
AgNPs than the anaerobic oral pathogenic bacteria. The
5 nm AgNPs presented the best antibacterial activity
against E. coli and F. nucleatum. Considering the higher
antimicrobial properties and lower toxicity of AgNPs
compared to those of Ag compounds, such as silver nitrate
and silver sulfadiazine, they could be used for the treatment
of periodontal pathogens with greater benefits. Recently,
Agnihotri et al. reported the complete and detailed inves-
tigation for size-specific antibacterial efficacy of AgNPs
[37]. The AgNPs of different sizes (5, 7, 10, 15, 20, 30, 50,
63, 85 and 100 nm) were synthesized using sodium boro-
hydride as a primary reductant and trisodium citrate as a
reductant as well as a stabilizing agent. The synthesis of
nanoparticles was based on the co-reduction approach
using a two-stage thermal treatment as shown in Fig. 1.
From the results, the antibacterial efficacies of the AgNPs
with [10 nm size were significantly improved as con-
firmed through delayed bacterial growth kinetics, corre-
sponding MIC/MBC values, and disk diffusion tests. The
AgNPs with an average diameter of 5 nm showed more
potent bactericidal activity against all the tested strains
[(Gram-negative (E. coli MTCC 443, E. coli MTCC 739)
and Gram-positive (B. subtilis MTCC 441, and S. aureus
NCIM5021)] compared to AgNPs with 7 and 10 nm
diameters at the same bacterial concentrations. In conclu-
sion, the smallest AgNPs (5 and 10 nm) showed improved
biocidal activity towards many different microbial strains.
Song et al. investigated the shape-dependent antibacte-
rial properties of silver nanoparticles [38]. There are many
literatures suggesting the size dependency of the antibac-
terial activity of the nano-silver, but Song’s group provides
a novel angle of the shape dependency of the AgNPs’
bactericidal capabilities. The silver nanoparticles with
different shapes were prepared by seeded growth method
(spherical) and solution phase method (rod and triangle
shape). The antibacterial activity of AgNPs with different
shapes was tested against Gram-negative bacteria E. coli.
The silver nanoparticles were characterized by UV–visible
spectroscopy and energy filtering transmission microscopy
(EFTEM). The UV–visible spectra and TEM images con-
firmed the spherical shape of the nanoparticles. The
EFTEM images (as shown in Fig. 1) for the rod and the
truncated triangle AgNPs were further confirmed by
OPML-XRD pattern and TEM. The bacterial killing
kinetics of the AgNPs were examined and determined by
absorbance measurements at 600 nm. The total silver
concentration content was quantified by ICP-MS. The sil-
ver content at 12.5 lg and above (50 and 100 lg) showed
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100 % bacterial inhibition in spherical nanoparticles. Full
bacterial inhibition at 10 lg of silver content was observed
for truncated triangular AgNPs. Compared to the other
shapes of silver nanoparticles, the truncated triangular
AgNPs were the most effective in preventing bacterial
growth. This phenomenon was explained by the percent
active facet of the various AgNPs. The high percent
composition of [111] facet of the top basal plane of the
truncated triangular AgNPs observed via the OPML-XRD
results provide insight into the truncated nanoplates’ high-
atomic density structure, which is understood to be the
major contributing factor in its enhanced bactericidal effi-
cacy. For comparison, pentagonal rod-shaped and spherical
silver nanoparticles exhibited a lower percentage of [100]
facet and lower antibacterial activities. By association, the
high-atom-density structures seem to be responsible for the
increase in bacterial growth inhibition, possibly due to the
increase in the level of interaction between the reactive
silver ions and the bacterial membrane at an atomic level
(Fig. 2).
The use of crown ether solution is a different approach
in silver nanoparticle preparation. Berdnikova et al. utilizes
a crown ether-mediated photochemical reduction, a syn-
thetic technic advantageous in both spatial and temporal
control, of silver ions in silver nanoparticle formation [39].
In this study, a mixture of cationic DNA intercalator,
benzo[b]quinolizinium-crown ether, and DNA was
explored as a AgNP formation moiety in order to avoid
undesired degradation as a result of the exposure to high-
energy light needed for the AgNP synthesis, as shown in
Fig. 3. The crown-ether acted as a mediator between the
DNA and the Ag?. The DNA intercalator acted as a light
harvesting photosensitizer for the electron transfer reaction
to initiate the process of the silver ion reduction. The high
binding affinity of the crown ether to Ag? provides a close
proximity between the different components of this ternary
composite, which yields the following benefits: high effi-
ciency in AgNP synthesis, formation of stable AgNPs, and
improvement in the reproducibility of size. The utilization
of crown ether in the AgNP formation process has been
researched quite extensively, but not much in the direction
of its antibacterial activity. Due to the variation in the
synthesis step, the products may exhibit a different level of
antibacterial activity. The ability to enhance the control of
the AgNP parameters may be contributed to the physical
binding of the silver ions at a molecular level. In another
study, crown ether was embedded in a polymer, poly(-
styrene), in order to provide a more flexible binding
structure for the silver nanoparticles [40]. The modifica-
tions of the crown ethers seem to be the deciding factor in
the various silver nanoparticle mediating molecules.
Although efficient and easy to operate, crown ethers’
presence in the silver nanoparticle sample will significantly
increase its cytotoxicity not only against bacteria, but also
against healthy cells. Furthering the research of the crown
ethers and increasing its biocompatibility via enhanced
purification or modification of the crown ether itself, seems
necessary in the field in order for the crown ether synthe-
sized AgNPs to be utilized in wound treatment. Aside from
the bactericidal properties of the crown ether silver
Fig. 1 EFTEM images of silver nanoparticles. a Spherical nanoparticles synthesized by citrate reduction. b Silver nanoparticles of different
shapes. c Purified rod-shaped nanoparticles [38]. Reproduced by permission of The American Society for Microbiology
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Fig. 2 EFTEM images of E. coli cells. a Untreated E. coli. Flagella
can be seen. b E. coli grown on agar plates supplemented with Ag?
(AgNO3). Arrows indicate partially damaged membranes. These cells
are viable. c E. coli treated with triangular silver nanoplates. Silver
nanoparticles appear as dark irregular pits on the cell surface.
d E. coli treated with spherical silver nanoparticles. e Enlarged image
of part of the bacterial cell membrane treated with triangular silver
nanoparticles. The cell membrane is damaged at multiple locations
[38]. Reproduced by permission of The American Society for
Microbiology
Fig. 3 A schematic
representation of the
photoinduced reduction of Ag?
by DNA-bound
benzoquinolizinium 1a [39].
Reproduced by permission of
The Royal Society of Chemistry
(RSC) on behalf of the Centre
National de la Recherche
Scientifique (CNRS) and the
RSC
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nanoparticles, the material has been used in colorimetric
detection of metal ions with superb sensitivity. The col-
orimetric detection of AgNPs utilizes its ability to recog-
nize metal ions and alter the solution’s optical properties by
aggregation, thus simplifying the detection method [41].
Ratnarathorn et al. developed a simple AgNP-bound paper-
based copper colorimetric sensing devices [42]. These
devices allowed the users to rapidly and easily detect the
presence of copper in solutions with a detection limit of
7.8 nM with the naked eye. The speed, ease of operation,
low detection limit, and mobility of the paper devices make
this colorimetric detector useful and marketable. Unlike
most metal ions, the detection of Pb2? ions were not
readily detected by ACE-AgNP based colorimetric meth-
ods. In order to overcome the limitations of detecting lead
ions, dynamic light scattering was used to detect Pb2? ions
with ultra-sensitivity using aza-crown-ether modified
AgNPs [43]. The use of nanoparticles’ unique plasmon
resonance allows for the sensitive detection of various
metal ions in solution, which is ideal in the detection of
such substances in environmental field studies of water.
Enhancing the bactericidal efficiency of AgNPs
The antimicrobial property of silver nanoparticles is one of
the most useful aspects of the material. There has been a
great deal of research in improving the efficacy of bacterial
inhibition from silver nanoparticles. The improvement in
the antibacterial efficacy is essential as silver nanoparticles
do exhibit toxicity at levels above the threshold concen-
tration. Hence, a material that exhibits the same amount of
antibacterial activity at a lower concentration may be
necessary to decrease the possibility of causing unwanted
damage in the cells. Researchers have studied, improved,
and developed a variety of methods to synthesize novel
silver nanoparticles. The bacteria killing activities of the
products were tested by treating different kinds of bacteria
with the materials and monitoring the cells. Reports of
novel synthetic methods leading to greater bactericidal
activity have been prevalent in the field of nanotechnology.
Silver nanoparticles prepared by using a blend of
reducing agents D-glucose and hydrazine were better able
to limit the growth of bacteria [44]. The stability of the
nanoparticles was tested over a period of 4 weeks to ensure
their long-term molecular stability. The blend-reduced
silver nanoparticles were tested on S. aureus and ampi-
cillin-resistant S. aureus on liquid broth, inoculation, and
agar plates. This paper also reported that the antibiotic
resistance to ampicillin of the bacteria was not a factor in
hindering the antibacterial inhibition of the prepared
nanoparticles. Furthermore, Dr. Shrivastava’s group
reported a more specific mechanism that may be respon-
sible for silver’s antibacterial property; the silver
nanoparticles anchored to and penetrated the cell wall of
bacteria, then modulated its signaling by dephosphorylat-
ing major peptide substrates of tyrosine residues [44]. This
mechanism was supported by the observation of noticeable
dephosphorylation in two peptides of E. coli and S. typhi.
Tyrosine phosphorylation is responsible for activating
UDP-glucose dehydrogenases and RNA polymerase sigma
factors [45]. Dephosphorylation of the peptides may sug-
gest the inhibition of the enzymes and critically impact the
growth of bacteria [45]. Understanding and utilizing the
bacterial signal transduction disruption of silver nanopar-
ticles will aid in the development of highly efficient
antibiotic nanomaterials. Certain studies took a simple, but
novel approach of enhancing the antibiotic activity of silver
nanoparticles by forming combinations of antibiotics and
silver nanoparticles. Combining antibiotics and capped
silver nanoparticles seemed to synergistically augment the
antibacterial activities of both components. Dr. Kora and
Fig. 4 The synthesis sequence for silver chlorhexidine nanoparticles in a reverse microemulsion. Reprinted with permission from Pal et al. [17].
Copyright 2009 American Chemical Society
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Dr. Rastogi reported the levels of enhancement in
antibacterial activity from various combinations of silver
nanoparticles and antibiotics. According to the study, the
different combinations of sodium dodecyl sulfate (SDS)
capped and polyvinylpyrrolidone (PVP) capped silver
nanoparticles with ampicillin, tetracycline, and strepto-
mycin all resulted in enhancements in their antibiotic
activities compared to that of the individual components,
when tested on S. aureus and E. coli [46]. The PVP-capped
silver nanoparticles exhibited the greatest enhancement in
bactericidal activity, especially in association with strep-
tomycin on S. aureus and ampicillin on E. coli, at 45.4 and
50.0 %, respectively. The silver nanoparticles showed
promising results in enhancing the antibiotic efficacy of
already established antibiotics. Further research in this area
may lead to discoveries in combinations that induce addi-
tionally enhanced antibacterial activities. Also diversifying
the components of the combinations may allow for
improvements in efficacy by attacking the bacteria from
different approaches simultaneously. Polymer micelles
embedded with silver nanoparticles showed strong bacte-
ricidal activity. Selective hydrolysis of poly(vinyl acetate)-
b-poly(acrylonitrile) copolymer, synthesized through a
radical polymerization, resulted in a new amphiphilic
poly(vinyl alcohol)-b-poly(acrylonitrile) [47]. The amphi-
philic block copolymer product was used as a nanoreactor
to form silver nanoparticle-embedded micelles by self-
assembly. The micelles presented strong bactericidal
effects on E. coli, S. aureus, P. aeruginosa, and spore
solutions of Bacillus subtilis [47]. Creating a nanocom-
posite consisted of different structures is a more complex,
but effective way of increasing silver nanoparticles’ effi-
cacy in preventing the growth of bacteria. Liang’s group
reported the development of a sandwich-like antibacterial
reagent that proved to be more effective than simple silver
nanoparticles [3]. AgNPs/halloysite nanotubes/graphene
nanocomposites (Ag/HNTs/rGO), sandwich-shaped
reagents from the study, consisted of multiple parts: hal-
loysite nanotubes, silver nanoparticles, graphene oxide
nanosheets, and DOPA or L-3,4-dihydroxyphenylalanine.
According to the paper, the reagent was formed by a single
step method of forming silver nanoparticles by reducing
DOPA at the GO nanosheets or surface of HNTs. DOPA
acts as an adhesive for all the components keeping the
structure together by utilizing its adhesion properties. The
group confirms the formation of the nanocomposites
through transmission electron microscopy (TEM),
HRTEM, energy dispersive spectrum (EDS), and FTIR.
The increase in surface area was measured using the
adsorption of N2. E. coli and S. aureus was used as the
bacteria models in the measurement of the Ag/HNTs/rGOs
antimicrobial activity. The bactericidal efficacy of the
synthesized product was compared to that of the starting
materials: graphene oxide, silver, silver nanoparticle
packed halloysite nanotubes, and silver nanoparticles
attached to graphene oxide nanosheets. The novel sand-
wich-shaped nanocomposites exhibited the lowest MIC
among the various test groups at 2 lg/ml [3]. The effect of
the different oxidation states of silver was studied by
forming stable silver complexes with silver oxidation states
1, 2, and 3 [48]. Silver (I) chlorhexidine was prepared
through precipitating the complex in situ in a weakly acidic
aqueous solution of AgNO3. The oxidation of Ag (I) fol-
lowed by the complexation with chlorhexidine yielded
silver (II) chlorhexidine. The antibacterial activities of both
materials were measured by the determination of MICs and
MBCs on Acinetobacter calcoaceticus, Citrobacter fre-
undii, E. faecalis, Klebsiella pneumonia, P. acnes, Pseu-
domonas aeruginosa, S. epidermidis, and S. aureus. The
higher valent Ag(II)CHX exhibited the lowest MIC and
MBC in all bacteria. The killing kinetics of the compound
were also monitored through monitoring the compound-
treated bacteria culture as a variable of time. Overall, the
synthesized AgCHX compounds were able to reach its
bactericidal endpoint, which was designated as the pres-
ence of a decrease in the level of cfu/mL equal to or
[99.9 %, much faster than CHX, AgNO3, and silver
sulfadiazine. Trivalent silver polydiguanide complex
nanocomposites were synthesized via oxidation of silver
(I) followed by a reverse microemulsion complexation
reaction using a polydiguanide, as shown in Fig. 4 [17].
The antibacterial activity of trivalent Ag(III)CHX was
also tested in the same 8 bacteria species as Ag(II)CHX
and Ag(I)CHX. The trivalent silver nanoparticles exhib-
ited better antibacterial activities compared to those of
chlorhexidine, AgNO3, and silver sulfadiazine. These
results confirm the strengthening of the bactericidal
activity of nano-silver produced by the high valency of
silver.
Wound-healing properties of conjugated silver
nanoparticles
Wound-healing is a complex biological process that occurs
as a mean of maintaining the human body. It undergoes
various processes that include: cell proliferation, inflam-
mation, migration, angiogenesis and extracellular matrix
(ECM) production [49]. Initially, neutrophils, monocytes,
and lymphocytes surround the wounded area. In the prolif-
eration phase endothelial cells, fibroblasts, and other types
of cells gather in the wounded area and start to repro-
duce, release matrix materials, and form functional capil-
laries and layers of epithelial cells that spread over the open
wound. In the final phase, matrix materials and collagen are
secreted and remodeled to fix tissue strength.
58 Int Nano Lett (2016) 6:51–63
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Silver and silver-related materials such as silver sulfa-
diazine, have been well explored as topical agents for
wound treatment. These antibiotic compounds are prone to
cause antibiotic resistance or inhibition during the wound-
healing process. For instance, silver sulfadiazine increases
wound epithelialization but impairs wound contraction,
which is a vital part of the repair process that pulls the
wound edges together to reduce the defect [50]. Similarly,
antibiotic sulfamylon demonstrated decreased keratinocyte
growth rates [51]. In addition to this, other antibiotic agents
in high concentrations produce injurious effects on
endothelial and fibroblasts cells [52]. Due to all the reasons
presented, the development of a novel and more effective
system of antibacterial/proliferative wound treatment will
prove beneficial in improving the quality of wound
treatment.
A large number of silver-based dressings is cur-
rently available in the market. Silver in the form of
impregnated bandages or as topical creams are used as
wound treatment agents. Also, it is used in the form of
fibers, polymeric scaffolds impregnated and coated with a
silver salt or in a nano-particulate form. The silver-based
dressings exhibit fast and broad-spectrum bactericidal
activity against various pathogenic bacteria species. How-
ever, there are not many reports available on the direct
wound-healing mechanism by silver or silver nanoparti-
cles. Recently, a few research groups have developed novel
silver-based materials such as scaffolds, composites and
hydrogels that combine the killing of microbes and healing
of wounds that may be useful in the field of wound repair
systems.
In a recent study by Heo et al., a blend of natural and
synthetic polymers containing nanofiber scaffolds and
gelatin was prepared by electrospinning [53]. Along with
the blended polymer solution, silver sulfadiazine (SSD)
was mixed in and introduced into the nanofibers after the
electrospinning method. The nanofiber scaffolds containing
SSD served as a substrate for skin repair, but also delivered
the chemical of interest in a controlled manner to stimulate
regeneration. The controlled release of the drug was cap-
able of controlling the reproduction of a wide array of
bacteria and promoting damage restoration through stim-
ulation and the prevention of infections leading to the
enhancement of the burn-wound closure rate.
During the wound repair process, maintaining adequate
moisture levels by avoiding dehydration around the wound
area is critical. For this reason, hydrogels are preferred
since they are able to maintain a moist environment at the
wounded site, act as a barrier to microorganisms, and serve
as a superior biocompatible material towards wound heal-
ing. Zengjie et al. have developed a wound dressing
material comprising a Ag/graphene polymer hydrogel for
the effective killing of bacteria and the acceleration of
wound healing [54]. Various hydrogels were synthesized
by the crosslinking of Ag/graphene composites with N,N0-
methylene bisacrylamide and acrylic acid at different
concentrations. Hydrogels prepared with the optimal gra-
phene to silver mass ratio of 1:5 exhibited stronger
antibacterial abilities compared to those of other hydrogels.
Also, the optimal hydrogel exhibited various desirable
properties including good biocompatibility, high swelling
ratio, and high extensibility. Moreover, the efficacy of the
product was tested in vivo on rats to check its healing
potency. A histological examination of the material
revealed that the hydrogel assists the reconstruction and
thickening of the epidermis during the 15-day period of
wound repair. Thus, multifunctional composites like gra-
phene/silver hydrogels exhibited excellent antibacterial and
wound closure properties for the development a novel
wound dressing.
Song et al. developed multifunctional composites with
both antibacterial and wound-healing properties [55]. In
this work, a multifunctional therapeutic agent consisting of
a wound-healing polypeptide histatin-1 (Hst) and a highly
bactericidal agent silver(II)chlorhexidine complex,
Ag(II)CHX, was developed. Ag(II)CHX was first synthe-
sized on a large scale then combined with the wound-
healing polypeptide. These composites showed higher
bactericidal activity against various pathogens.
Cell spreading is a very important component of the
reepithelialization phase. Histatins are polypeptides iso-
lated from human saliva. These peptides were studied for
the in vitro epithelial cell migration-inducing properties of
saliva [56]. Histatins also enhanced reepithelialization by
inducing migration and spreading of cells. Histatin-1 (Hst-
1) and Histatin-2 (Hst-2) (12–38 Hst-1) were used as potent
wound closure peptides, whereas Histatin-5 (Hst-5),
another antimicrobial peptide of the histatin family, failed
to produce any wound closure properties. There-
fore, the effect of Ag(II)CHX on the cell-spreading activ-
ity of Hst-1 was tested by comparing the samples with and
without the presence of Ag(II)CHX. The concentra-
tions silver complexes were selected according to its MIC
values (0.12–3 lM). Interestingly, cell-spreading assay
performed for silver complex showed no wound closure
property as shown in Fig. 5a, but it also did not impair the
cell-spreading activity of the Hst-1 (Fig. 5b). The dose-
dependent activity of a silver complex, Hst-1[Ag(II)CHX],
on cell-spreading was determined by measuring the cell-
free gap. The microscopy images showed that the silver
complex did not increase cell-spreading as shown in
Fig. 5a, but it also did not affect the cell proliferation
promoting properties of the Hst-1 (Fig. 5b). Relative cell-
free gap (RGt) calculated at various time intervals, showed
Hst-1-[Ag (II) CHX] conjugate had cell-spreading activity.
The conjugate’s activity was similar to that of Hst-1
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(Fig. 5c). The synthesized Hst-1, regardless of the AgCHX
attachment, concentration dependently enhanced cell-
spreading. While relative cell-spreading (RGs) in the
presence of 0.2 lM Hst-1 was comparable to the control,
higher concentrations of the peptide sharply increased the
RGs for 12 h and complete cell coverage was achieved
much faster than the control. Figure 5d demonstrates the
increased level and rate of cell-spreading as a result of
increased concentrations of Hst-1. The combination of
antibacterial silver complex and wound-healing peptide
presents a novel wound-healing system that aids in con-
trolling and killing the bacteria around wound area and
increase the proliferation during the wound-healing
process.
Fig. 5 Representative micrographs (a, b) and graphical representa-
tion of the results (c, d) of the in vitro cell-spreading assays. The cells
were supplemented with different amounts of active agents and
microscopic images were captured at different time intervals. The
solid lines in images (a, b) represent the cell-free gap boundaries at
0 h. The relative cell-free area (RGt) (c), and the relative spreading
(RSt) (d) at a given time t were calculated by quantifying the cell-free
area from the micrographs. The data represent mean ± SD; n = 1.
*P\ 0.01 vs. appropriate control [55]. Reproduced by permission of
The Royal Society of Chemistry (RSC) on behalf of the Centre
National de la Recherche Scientifique (CNRS) and the RSC
60 Int Nano Lett (2016) 6:51–63
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Conclusion
The versatility of silver nanoparticles is derived from its
capability of modification. Size variation affects the potency
of the antibacterial particles. Silver nanoparticles in different
shapes also exhibit differing levels of antibacterial activities.
The ease in the control of the size and shape of the
nanoparticles grants the freedom in the manipulation of the
particles as necessary. Incorporation of silver nanoparticles
with pre-established antibiotics, variation in the synthetic
method by using different reductants and stabilizers, conju-
gation of the silver nanoparticles with ligands that exhibit
antibiotic activities themselves, formation of complex
nanocomposites, and increasing the valency of the silver ion
were all successful in enhancing the nanoparticles’ ability to
inhibit bacterial growth through various mechanisms, some
of which are still unknown. Further stretching the utility of
the silver nanoparticles, the particles were incorporated in
several experimental wound treatment systems. By taking
advantage of the antimicrobial activities of AgNPs in a
variety of forms and cell proliferation activities of other
materials, wound repair aid systems with better efficacy and
safety can be developed in the future. With peptide conju-
gation capabilities of the nanoparticles, a whole new spec-
trum of applications was open as a field of modification
research. The immense range of utility of the AgNPs comes
with certain environmental and health safety responsibilities.
Potential dangers of this material need to be studied along
with the advancement of the nanoparticulates as those
properties advantageous in the antibacterial applications
may pose unprecedented environmental threats. This review
presents the utilization, modification, and determination of
antibacterial activity of many different types of silver
nanoparticles exhibiting AgNPs’ versatility. The versatile
capabilities of Silver nanoparticles should be researched
further to improve upon those applications that are being
used today and to discover new applications of the scientif-
ically promising silver nanoparticles. The green synthesis of
the silver nanoparticles have been increasingly gaining
interest for its reduction in the production of environmentally
harmful byproducts and potentially increasing the AgNPs
biocompatibility and decreasing its toxicity. Use of natural
products such as biopolymers in the preparation of nano-
silver seems promising in the development of medically
applicable silver nanoparticles. Enhancing AgNP’s bio-
compatibility, environmental sustainability in production,
antibacterial activity and reducing its cytotoxicity and side
effects should be considered as the major directions in
antibacterial AgNP research.
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